The FDA has approved Widaplik (telmisartan, amlodipine and indapamide) for the treatment of hypertension, including as initial treatment, to lower blood pressure.

The FDA has approved Widaplik (telmisartan, amlodipine, and indapamide) for the treatment of hypertension in adults.

Telmisartan, amlodipine; 40mg/5mg, 40mg/10mg, 80mg/5mg, 80mg/10mg; tabs. Take once daily. Initial therapy: 40/5mg or 80/5mg; may titrate at 2-week intervals to max 80/10mg. Add-on therapy ...

Discover comprehensive details about Telmisartan and Amlodipine, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it.

In a statement from Teva posted by the Food and Drug Administration, the recall affects all lots of combination tablets featuring the drugs amlodipine and valsartan and another combo drug ...

GMRx2 contains telmisartan, amlodipine and indapamide in three dose strengths: triple quarter doses (10 mg, 1.25 mg and 0.625 mg, respectively), triple half doses (20 mg, 2.5 mg and 1.25 mg ...

The polypill (Widaplik) — formerly known as GMRx2 — contains three separate drugs for treatment of high BP: telmisartan, an angiotensin receptor blocker; amlodipine, a calcium channel blocker ...

Review the side-effects of Telmisartan and Amlodipine as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication.

WIDAPLIK is a proprietary single pill combination of three medicines: telmisartan, amlodipine and indapamide and is available in three doses: a standard dose and two low doses. It is the first and ...

Customers and patients with medical-related questions, information about an Adverse Event or other questions about the Teva products being recalled should contact Teva’s Medical Information by ...